PL2913394T3 - Wspólne różnicowanie i aktywowanie monocytów od dawców allogenicznych dla dostarczenia prozapalnych komórek dendrytycznych - Google Patents
Wspólne różnicowanie i aktywowanie monocytów od dawców allogenicznych dla dostarczenia prozapalnych komórek dendrytycznychInfo
- Publication number
- PL2913394T3 PL2913394T3 PL15161369.2T PL15161369T PL2913394T3 PL 2913394 T3 PL2913394 T3 PL 2913394T3 PL 15161369 T PL15161369 T PL 15161369T PL 2913394 T3 PL2913394 T3 PL 2913394T3
- Authority
- PL
- Poland
- Prior art keywords
- monocytes
- differentiation
- activation
- dendritic cells
- allogeneic donors
- Prior art date
Links
- 230000004913 activation Effects 0.000 title 1
- 230000000735 allogeneic effect Effects 0.000 title 1
- 210000004443 dendritic cell Anatomy 0.000 title 1
- 210000001616 monocyte Anatomy 0.000 title 1
- 230000000770 proinflammatory effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/40—Nucleotides, nucleosides or bases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2304—Interleukin-4 (IL-4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/24—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/11—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells
- C12N2506/115—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells from monocytes, from macrophages
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12197687 | 2012-12-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2913394T3 true PL2913394T3 (pl) | 2016-12-30 |
Family
ID=47427250
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13814106T PL2788474T3 (pl) | 2012-12-18 | 2013-12-18 | Wspólne różnicowanie monocytów od dawców allogenicznych |
| PL15161369.2T PL2913394T3 (pl) | 2012-12-18 | 2013-12-18 | Wspólne różnicowanie i aktywowanie monocytów od dawców allogenicznych dla dostarczenia prozapalnych komórek dendrytycznych |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13814106T PL2788474T3 (pl) | 2012-12-18 | 2013-12-18 | Wspólne różnicowanie monocytów od dawców allogenicznych |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US9714413B2 (pl) |
| EP (2) | EP2913394B1 (pl) |
| JP (1) | JP6529439B2 (pl) |
| KR (1) | KR102148051B1 (pl) |
| CN (2) | CN105452449B (pl) |
| AU (1) | AU2013360793B2 (pl) |
| BR (1) | BR112015014270B1 (pl) |
| CA (1) | CA2895280C (pl) |
| DK (2) | DK2913394T3 (pl) |
| ES (2) | ES2591230T3 (pl) |
| HU (2) | HUE028895T2 (pl) |
| MX (1) | MX357491B (pl) |
| PL (2) | PL2788474T3 (pl) |
| RU (1) | RU2668816C2 (pl) |
| SI (2) | SI2913394T1 (pl) |
| WO (1) | WO2014096033A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI3460052T1 (sl) | 2017-09-20 | 2020-03-31 | Immunicum Ab | Izboljšane alogene dendritične celice za uporabo pri zdravljenju raka |
| US20200338173A1 (en) * | 2018-01-18 | 2020-10-29 | University Of South Florida | Dead antigen stimulated immature heterogenous dendritic cells as therapeutics for diseases |
| CN108660125A (zh) * | 2018-05-14 | 2018-10-16 | 武汉博百欧生物科技有限公司 | 一种从人体输血废弃物中提取中性粒细胞嗜天青颗粒的方法 |
| WO2020154424A1 (en) * | 2019-01-22 | 2020-07-30 | The Brigham And Women's Hospital, Inc. | Antigen-presenting neutrophil-derived dendritic cells and methods of use thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1259592A1 (en) * | 2000-01-11 | 2002-11-27 | Maxygen, Inc. | Monocyte-derived dendritic cell subsets |
| AU2002326463A1 (en) | 2001-07-25 | 2003-02-17 | Northwest Biotherapeutics, Inc. | Methods and apparatus for enrichment and culture of monocytic dendritic cell precursors |
| AU2003241252A1 (en) | 2002-06-06 | 2003-12-22 | Immunicum Ab | New method and composition for producing a cellular allogeneic vaccine |
| KR100585456B1 (ko) * | 2003-09-30 | 2006-06-07 | 국립암센터 | 동종 종양-관련 항원이 탑재된 수지상세포, 이의 제조방법및 이를 유효성분으로 하는 암 치료용 백신 조성물 |
| CA2504451A1 (en) * | 2004-08-10 | 2006-02-10 | Geron Corporation | Dendritic cell vaccines for treating cancer made from embryonic stem cells |
| EP3805367A1 (en) * | 2005-12-08 | 2021-04-14 | NorthWest Biotherapeutics, Inc. | Compositions and methods for inducing the activation of immature monocytic dendritic cells |
| EP1806395A1 (en) * | 2006-01-06 | 2007-07-11 | Stichting Sanquin Bloedvoorziening | Maturation of dendritic cells |
| EP1840206A1 (en) * | 2006-03-28 | 2007-10-03 | Gsf-Forschungszentrum Für Umwelt Und Gesundheit, Gmbh | Compositions for the preparation of mature dendritic cells |
| CN102597222B (zh) * | 2009-10-27 | 2015-07-15 | 因缪尼卡姆股份公司 | 用于增殖抗原特异性t细胞的方法 |
| EP2534242B1 (en) * | 2010-02-10 | 2016-04-20 | Immunicum AB | Improved composition for inhibiting tumor cell proliferation |
| US9492529B2 (en) * | 2011-04-13 | 2016-11-15 | Immunicum Ab | Method for priming of T cells |
| CN103502439B (zh) * | 2011-04-13 | 2016-10-12 | 因缪尼卡姆股份公司 | 用于抗原特异性t细胞增殖的方法 |
-
2013
- 2013-12-18 CN CN201380066722.0A patent/CN105452449B/zh active Active
- 2013-12-18 PL PL13814106T patent/PL2788474T3/pl unknown
- 2013-12-18 WO PCT/EP2013/077139 patent/WO2014096033A1/en active Application Filing
- 2013-12-18 BR BR112015014270-2A patent/BR112015014270B1/pt not_active IP Right Cessation
- 2013-12-18 HU HUE15161369A patent/HUE028895T2/en unknown
- 2013-12-18 JP JP2015547082A patent/JP6529439B2/ja active Active
- 2013-12-18 RU RU2015119164A patent/RU2668816C2/ru active
- 2013-12-18 SI SI201330281A patent/SI2913394T1/sl unknown
- 2013-12-18 DK DK15161369.2T patent/DK2913394T3/en active
- 2013-12-18 MX MX2015007800A patent/MX357491B/es active IP Right Grant
- 2013-12-18 PL PL15161369.2T patent/PL2913394T3/pl unknown
- 2013-12-18 US US14/653,184 patent/US9714413B2/en active Active
- 2013-12-18 CN CN201910284719.5A patent/CN110042081B/zh active Active
- 2013-12-18 EP EP15161369.2A patent/EP2913394B1/en active Active
- 2013-12-18 SI SI201330066T patent/SI2788474T1/sl unknown
- 2013-12-18 CA CA2895280A patent/CA2895280C/en active Active
- 2013-12-18 EP EP13814106.4A patent/EP2788474B1/en active Active
- 2013-12-18 ES ES15161369.2T patent/ES2591230T3/es active Active
- 2013-12-18 KR KR1020157015766A patent/KR102148051B1/ko active IP Right Grant
- 2013-12-18 DK DK13814106.4T patent/DK2788474T3/en active
- 2013-12-18 AU AU2013360793A patent/AU2013360793B2/en active Active
- 2013-12-18 ES ES13814106.4T patent/ES2548229T3/es active Active
- 2013-12-18 HU HUE13814106A patent/HUE027619T2/en unknown
-
2017
- 2017-06-15 US US15/623,530 patent/US10626371B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL264455A (en) | Progenitor cells of mesodermal lineage | |
| IL237479A0 (en) | Methods and compositions relating to eukaryotic cell modulators | |
| IL233980A0 (en) | Compositions and methods for producing a persistent population of t cells useful for the treatment of cancer | |
| EP2836224A4 (en) | COMPOSITIONS OF BIOZOOSE AND RELATED METHODS | |
| SG10201610915XA (en) | Methods and compositions for natural killer cells | |
| EP2879778A4 (en) | HIGHLY EFFICIENT SEPARATION AND MANIPULATION OF PARTICLES AND CELLS | |
| EP2761291A4 (en) | SYSTEM AND METHOD FOR SEPARATING CELLS AND / OR PARTICLES | |
| SG10201705024PA (en) | Methods and compositions for separating or enriching cells | |
| ZA201404483B (en) | Improvements in or relating to the encapsulation of perfumes | |
| PL3057604T3 (pl) | Kompozycje nanocząstek i sposoby jako nośniki czynników nutraceutycznych przez błony komórkowe i bariery biologiczne | |
| PT3321355T (pt) | Métodos e composições para a derivação clínica de uma célula alogénica e utilizações terapêuticas | |
| HK1209155A1 (en) | Generation of functional and durable endothelial cells from human amniotic fluid-derived cells | |
| EP2825635A4 (en) | SYSTEMS AND SUBSTANCES FOR THE CRYOPRESERVATION OF VIABLE CELLS | |
| GB201200458D0 (en) | Methods of preparing cells and compositions | |
| IL231663A0 (en) | Vaccines directed at presenting dendritic cells | |
| PL2913394T3 (pl) | Wspólne różnicowanie i aktywowanie monocytów od dawców allogenicznych dla dostarczenia prozapalnych komórek dendrytycznych | |
| SG11201500139SA (en) | Derivation and self-renewal of isi1+ cells and uses thereof | |
| EP2878666A4 (en) | INDUSTRIAL PREPARATION OF NATURAL KILLING CELLS (NKS) AND INJECTION USING HUMAN ALLOGENIC CARYOCYTES | |
| IL222343A0 (en) | Compositions comprising allogeneic th1 cells and uses thereof | |
| ZA201400696B (en) | Progenitor cells of mesodermal lineage | |
| GB201205051D0 (en) | Improvements in or relating to the encapsulation of perfumes |